ZimVie Reports First Quarter 2025 Financial Results

Core Viewpoint - ZimVie Inc. reported a net sales decrease of 5.2% for Q1 2025, but showed significant improvement in net loss and adjusted net income compared to the same period in 2024, indicating a focus on operational efficiency and profitability improvements [2][3][4]. Financial Performance - Net sales for Q1 2025 were $112.0 million, down 5.2% from Q1 2024, with a constant currency decrease of 4.1% [2][28]. - The net loss for Q1 2025 was $(2.6) million, an improvement of $8.9 million from a net loss of $(11.5) million in Q1 2024, resulting in a net loss margin of (2.3%), up 740 basis points from (9.7)% in Q1 2024 [3][4]. - Adjusted net income for Q1 2025 was $7.4 million, an increase of $5.2 million compared to Q1 2024 [3][4]. Earnings Per Share - Basic and diluted EPS for Q1 2025 were $(0.09), while adjusted diluted EPS was $0.27 [4][29]. Adjusted EBITDA - Adjusted EBITDA for Q1 2025 was $17.6 million, representing 15.7% of net sales, an increase of $5.1 million or 520 basis points from Q1 2024 [4][35]. Full Year Guidance - For the full year 2025, ZimVie projects net sales between $445 million and $460 million, adjusted EBITDA between $65 million and $70 million, and adjusted EPS between $0.80 and $0.95 [5]. Operational Focus - The company emphasizes a strong focus on execution and operational diligence to maintain its leading position in the dental market through innovation and education [2][8].